Patent infringement: Pfizer convinces US Patent Office to cancel two Moderna coronavirus vaccine patents Ruchika Sharma6 March 2025 5:56 PM ISTPfizer and BioNTech have convinced a U.S. Patent Office tribunal that two patents Moderna accused Pfizer-BioNtech of infringing were invalid. The...
Moderna's Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales Slump Farhat Nasim16 Feb 2025 9:30 AM ISTBengaluru: Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid...
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case Farhat Nasim15 Feb 2025 3:25 PM ISTBengaluru: Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare...
Moderna bags Health Canada nod for RSV vaccine for adults aged 60 years and older Ruchika Sharma11 Nov 2024 4:43 PM ISTCambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for active immunization for...
Merck, Moderna begin Phase 3 Trial of V940 with Keytruda in non small lung cancer Ruchika Sharma3 Nov 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Moderna, Inc., announced the initiation of INTerpath-009, a pivotal...
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit MD Bureau16 Oct 2024 3:51 PM ISTLondon: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...
Moderna lays out plan to slice research and development spending MD Bureau Team15 Sept 2024 10:45 AM ISTWashington: Shares of Moderna tumbled after the vaccine developer said it was cutting research and development spending and pushed back its time...
Moderna forecasts lower sales next year, shares near four-year low MD Bureau Team14 Sept 2024 11:34 AM ISTLondon: Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted...
FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain MD Bureau Team1 Sept 2024 10:45 AM ISTBengaluru: The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID...
FDA approves season's updated mRNA COVID vaccines for protection against current variants Dr. Kamal Kant Kohli24 Aug 2024 9:45 AM ISTThe U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to...
London HC decision fuels continued legal battle between Pfizer, Moderna over COVID vaccine patents Ruchika Sharma4 July 2024 4:10 PM ISTLondon: Pfizer and Moderna's legal dispute over their competing COVID-19 vaccines is poised to persist following a mixed ruling from London's...
Moderna files FDA application for JN.1 targeting COVID vaccine Ruchika Sharma11 Jun 2024 10:30 AM ISTCambridge: Moderna, Inc. has announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its...
